Pertaining to Friedrich’s Ataxia: New Therapy SNH6 May Work for Cardiomyopathy in FA, Mouse Study Says

Print Friendly, PDF & Email

SNH6, a new dual-action therapy, has the potential to restore mitochondria function and may ultimately be used to treat cardiomyopathy in patients with Friedreich’s ataxia (FA), a mouse study found. The compound’s dual mechanism allows it to both reduce the buildup of iron and modulate levels of important mitochondrial […]